Every severe viral infection since the Spanish Flu has stimulated interest in passive
immunotherapy, in the absence of antiviral treatment and a vaccine program [1]. The …

The authors of a systematic review and meta-analysis conclude that the benefit of
convalescent plasma (CP) in the treatment of COVID-19 is limited. Among other systematic …

Abstract Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus has
become a Public Health Emergency of International Concern. Among the various treatment …

Editorial The transfer of immunity from a protected to an infected host dates back to the end
of the XIXth century, on both experimental and clinical grounds. Perhaps the pioneer large …

The objective of this study was to highlight the global scientific effort to fight the SARS-CoV-
2, addressing the preliminary results of passive immunization through convalescent plasma …

The global pandemic of the new coronavirus SARS-CoV-2 not only has medical, economic
and social but also historical significance. In many parts of the world, the exponential …

On March 11th, 2020, the World Health Organization declared COVID‐19 infection as a
pandemic. Since it is a novel virus, there are basically no proven drugs or therapies; …

Soon after the onset of the epidemic, specific plasma therapy—after collection of fresh
plasma from convalescent individuals who had recovered from SARS-CoV-2 infection …

Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory coronavirus 2
(SARS-CoV-2), has rapidly spread since its first declaration by the World Health …

The collection and clinical use of COVID-19 convalescent plasma (CCP) as a therapy for
COVID-19 infection is under development and early use in many centers worldwide. We …